Peptide research into fat loss and metabolic regulation has expanded rapidly over the past five years. Several compounds — spanning GLP-1 receptor agonists, growth hormone secretagogues, and mitochondrial peptides — have demonstrated meaningful effects on adipose tissue in preclinical models. For researchers in Malaysia, access to these compounds through a local supplier is now significantly easier. This article outlines the most studied peptides in weight-loss research and what distinguishes them mechanistically.
Note: All peptides listed here are research compounds only. They are not approved for human use and are supplied exclusively for laboratory and research purposes.
1. Retatrutide — Triple Receptor Agonist
Retatrutide is currently the most potent investigational peptide in metabolic research, functioning as a triple agonist of the GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trial data published in 2023 showed weight reductions of up to 24% of body weight over 48 weeks — the highest recorded for any anti-obesity compound at that stage of development. Its glucagon receptor activity differentiates it from dual-agonists like tirzepatide by driving additional thermogenesis and hepatic fat oxidation. For a detailed breakdown, see our Retatrutide research article.
2. CJC-1295 + Ipamorelin — GH Secretagogue Stack
The combination of CJC-1295 (a GHRH analogue) and Ipamorelin (a selective GHRP) is among the most researched growth hormone secretagogue combinations. By stimulating pulsatile GH release without significantly elevating cortisol or ghrelin, this stack has been studied for its effects on lipolysis — the breakdown of fat stored in adipose tissue — particularly visceral fat. Elevated GH levels correlate with increased fat mobilisation and preferential lean mass preservation in research models. Our full analysis is available in the CJC-1295 & Ipamorelin article.
3. Tesamorelin — Targeted Visceral Fat Reduction
Tesamorelin is a stabilised GHRH analogue with an established clinical track record — it is FDA-approved in the US for HIV-associated lipodystrophy, specifically targeting visceral adipose tissue (VAT). In research models, Tesamorelin has demonstrated selective reduction of VAT without meaningful effects on subcutaneous fat, suggesting a mechanism tied to GH's role in hepatic lipid metabolism. For researchers studying abdominal fat or metabolic syndrome, Tesamorelin is a mechanistically precise tool. Read the full Tesamorelin research article for more.
4. MOTS-c — Mitochondrial Metabolic Regulator
MOTS-c is a mitochondria-derived peptide encoded in mitochondrial DNA. Research has identified it as a regulator of metabolic homeostasis — it activates the AMPK pathway, which governs cellular energy balance, and has demonstrated effects on insulin sensitivity and adipogenesis in preclinical models. Notably, MOTS-c levels decline with age, paralleling the decline in metabolic efficiency seen in ageing subjects. For researchers studying the intersection of ageing and metabolic disease, MOTS-c represents an important research tool. See our MOTS-c research article.
5. Ipamorelin — Selective GH Release Without Cortisol Elevation
Used alone or as part of a stack, Ipamorelin is notable for its selectivity — it stimulates GH release via the GHSR-1a receptor without causing the cortisol and prolactin spikes associated with older GHRPs like GHRP-6. Since elevated cortisol promotes fat storage (particularly visceral fat), Ipamorelin's clean GH release profile makes it a preferred tool for research into body composition. See the full Ipamorelin research article.
Where to Buy These Peptides in Malaysia
Concept Peptides stocks all of the above compounds in lyophilised, research-grade format. Each product is:
- Third-party tested to 99%+ purity with Certificate of Analysis
- Shipped from within Malaysia — 1–3 business day delivery
- Supplied with free BAC Water for reconstitution
- Available via local payment methods (bank transfer, FPX)
Choosing the Right Compound for Your Research
The appropriate peptide depends on the specific metabolic pathway your research targets. Retatrutide is best suited for comprehensive GLP/GIP/glucagon axis studies; CJC-1295 + Ipamorelin for GH-mediated lipolysis research; Tesamorelin for visceral fat-specific studies; MOTS-c for mitochondrial-metabolic axis research. Researchers ready to source Retatrutide can visit our guide on how to buy Retatrutide Malaysia. For context on the broader GLP-1 class, see our GLP-1 peptides Malaysia overview, and for a head-to-head mechanistic comparison, see our Retatrutide vs Semaglutide article. Contact our team via WhatsApp or Telegram if you need guidance on specifications or availability.